oleanolic acid has been researched along with ginsenoside rg3 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bastow, KF; Chan, HH; Hwang, TL; Lee, KH; Li, DT; Qian, K; Reddy, MV; Wu, TS | 1 |
Huang, H; Lian, XY; Liang, Y; Ye, X; Yu, S; Zhang, Z | 1 |
Kashimoto, T; Kudo, K; Tachikawa, E; Takahashi, E | 1 |
Guan, Q; Guo, Y; Li, Y; Lv, S; Shang, E; Shi, L; Sun, S; Xiao, H; Yu, X; Zhao, C | 1 |
4 other study(ies) available for oleanolic acid and ginsenoside rg3
Article | Year |
---|---|
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
Topics: Antineoplastic Agents, Phytogenic; Cytochalasin B; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Inhibitory Concentration 50; KB Cells; Molecular Structure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nuclear Magnetic Resonance, Biomolecular; Panax; Pancreatic Elastase; Plant Roots; Saponins | 2011 |
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
Topics: Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioma; Humans; Phenols; Plant Extracts; Rats; Saponins; Structure-Activity Relationship; Triterpenes | 2014 |
Properties of ginseng saponin inhibition of catecholamine secretion in bovine adrenal chromaffin cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Cardiac Glycosides; Catecholamines; Cattle; Central Nervous System Agents; Chromaffin Cells; Dose-Response Relationship, Drug; Ginsenosides; Glycyrrhizic Acid; Oleanolic Acid; Panax; Plants, Medicinal; Sapogenins; Saponins | 1998 |
Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Carriers; Drug Liberation; Female; Ginsenosides; Hyaluronic Acid; Lipids; Mice; Nanostructures; Neoplasms; Oleanolic Acid; Particle Size; Static Electricity; Tissue Distribution; Triterpenes; Ursolic Acid | 2020 |